Search Results 1601-1610 of 17122 for monoclonal antibody

  1. A Study to Evaluate Tadalafil and Lenalidomide with or without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma - Mayo Clinic

    POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein [M-protein] and skin changes);; Non-secretory ...

  2. Publications - Ande M. Rumilla, M.D. - Mayo Clinic

    ... Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer. Thyroid. 2020 Sep; 30 (9):1254-1262 Epub 2020 July 29. View PubMed; DeLeon TT ...

  3. Mayo Clinic Proceedings: In the Limelight, April 2021

    ... antibody neutralization. A specific mutation may exert countervailing effects, for example, producing strains that may more likely escape from the effects ...

  4. Biological therapy for cancer - Care at Mayo Clinic

    Therapeutic antibodies and immunologic conjugates. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Feb. 10 ...

  5. Mayo Clinic 150 Collection of Stories Title: Lowering Rejection Risk in Organ Transplants / Date: March 2014 Intro: Among the

    In combined kidney-liver or heart-liver transplants his team had observed a reduction in antibodies to that donor. However, in multiple organ transplants,.

  6. Meningococcal vaccine, diphtheria conjugate (intramuscular route) - Side effects & uses - Mayo Clinic

    The vaccine works by causing your body to produce its own protection (antibodies) against the disease. The following information applies only to the ...

  7. Cancer Immunology and Immunotherapeutics Research Program

    Aim 2: The purpose of this aim is to develop innovative immune interventions using antibody-mediated targeting and oncolytic viral targeting. Aim 3: In this aim ...

  8. A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

    Pathologically confirmed MCL, with documentation of monoclonal CD20+ B cells that have a chromosome translocation t(11;14)(q13;q32) and/or overexpress cyclin D1 ...

  9. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Must be refractory to anti-CD38 antibody (e.g., daratumumab or isatuximab) ... antibody result and known quantitative hepatitis C [HCV] ribonucleic acid ...

  10. Uncovering Signaling Pathways That Regulate Invasion and Metastasis of Cancer Cells - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    Using a unique tool, an antibody that recognizes phosphorylated PKD substrates, the lab has identified additional targets for protein kinase D (PKD).